Evidence map›Paper›PMID 42581047›Full record

ArticleNature communications2026

PA200 modulates immunoproteasome structure and activity.

Dušan Živković, Amélie Bosc-Rosati, Angelique Sanchez Dafun, Fatme Mourtada, Przemysław Grygier, Ayse Seda Yazgili, Marijke Jansma, Michał Rawski, Anna Czarna, Stefan Bohn and 11 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Dušan Živković *Université de Toulouse, CNRS, IPBS, Toulouse, France.ORCID 0000-0001-5794-4422
Amélie Bosc-Rosati *Université de Toulouse, CNRS, IPBS, Toulouse, France.ORCID 0009-0003-3692-6745
Angelique Sanchez Dafun *Université de Toulouse, CNRS, IPBS, Toulouse, France.ORCID 0000-0003-0559-850X
Fatme MourtadaResearch Center Borstel/Leibniz Lung Center, RG Immunology and Cell Biology, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Borstel, Germany.
Przemysław GrygierMalopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, Krakow, Poland.
Ayse Seda YazgiliComprehensive Pneumology Center (CPC), University Hospital of the Ludwig -Maximilians-University (LMU) and Helmholtz Center Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.ORCID 0000-0001-8485-9653
Marijke JansmaMolecular Targets and Therapeutics Center, Institute of Structural Biology, Helmholtz Munich, Neuherberg, Germany.
Michał RawskiNational Synchrotron Radiation Centre SOLARIS, Jagiellonian University, Kraków, Poland.ORCID 0000-0002-8553-7637
Anna CzarnaMalopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, Krakow, Poland.
Stefan BohnTUM School of Natural Sciences, Department of Bioscience, Bayerisches NMR Zentrum, Technical University of Munich, Garching, Germany.ORCID 0000-0001-9196-622X
Krzysztof M ZakMolecular Targets and Therapeutics Center, Institute of Structural Biology, Helmholtz Munich, Neuherberg, Germany.
André Santos Dias MourãoMolecular Targets and Therapeutics Center, Institute of Structural Biology, Helmholtz Munich, Neuherberg, Germany.
Norbert ReilingResearch Center Borstel/Leibniz Lung Center, RG Microbial Interface Biology, German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.ORCID 0000-0001-6673-4291
Linda ZemkeResearch Center Borstel/Leibniz Lung Center, RG Microbial Interface Biology, German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.
Kai GuoResearch Center Borstel/Leibniz Lung Center, RG Immunology and Cell Biology, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Borstel, Germany.ORCID 0000-0002-4291-4439
Jürgen BehrDepartment of Medicine V, LMU University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.
Odile Burlet-SchiltzUniversité de Toulouse, CNRS, IPBS, Toulouse, France.
Grzegorz M PopowiczMolecular Targets and Therapeutics Center, Institute of Structural Biology, Helmholtz Munich, Neuherberg, Germany. grzegorz.popowicz@helmholtz-munich.de.ORCID 0000-0003-2818-7498
Julien Marcoux *Université de Toulouse, CNRS, IPBS, Toulouse, France. julien.marcoux@ipbs.fr.ORCID 0000-0001-7321-7436
Silke Meiners *Research Center Borstel/Leibniz Lung Center, RG Immunology and Cell Biology, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Borstel, Germany. smeiners@fz-borstel.de.ORCID 0000-0003-3678-7995
Marie-Pierre Bousquet *Université de Toulouse, CNRS, IPBS, Toulouse, France. marie-pierre.bousquet@ipbs.fr.ORCID 0000-0003-2680-8932

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-10-INBS-08Agence Nationale de la Recherche (French National Research Agency) ANR-24-INBS-0015Agence Nationale de la Recherche (French National Research Agency) ANR-PA200_IN_IPFBundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 16GW0287Deutsche Forschungsgemeinschaft (German Research Foundation) ME2002/6-1, BE1305/9-1Deutsche Forschungsgemeinschaft (German Research Foundation) TRR 387/1 - 514894665
6 · The paper itself

Abstract

The proteasome activator PA200 binds to the catalytic core of both standard proteasome (s20S) and the immunoproteasome (i20S); however, whether PA200 uses the same mechanisms to activate i20S remains unknown. In this work, the cryo-EM structures of singly- and doubly-capped i20S-PA200 complexes, combined with complementary in vitro biochemical assays, show that binding of the first PA200 induces allosteric bending of the i20S and widens the opposite α-ring, promoting higher PA200 occupancy and stronger activation compared to the s20S. PA200 also selectively modulates i20S proteolytic activity by enhancing peptide production and shifting cleavage specificity toward caspase-like activity. In cells and tissues co-expressing PA200, s20S, and i20S, PA200 preferentially associates with the i20S. Moreover, PA200 and i20S catalytic subunits are differentially regulated, with PA200 playing a potential role in regulating the i20S subunits' expression. Overall, these findings suggest that PA200 contributes to the regulation of i20S function and dynamics.

Indexed as

Proteasome Endopeptidase ComplexAnimalsCatalytic DomainCryoelectron MicroscopyHEK293 CellsHumansModels, MolecularProtein BindingProteolysisProteasome Endopeptidase Complex

Identifiers

PMID42581047
PMCPMC13463089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.